查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654274

醫藥快速微生物檢測市場規模、佔有率、趨勢分析報告：按產品、方法、應用、地區、細分市場預測，2025-2030 年

Pharmaceutical Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

快速藥物微生物檢測市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球醫藥快速微生物檢測市場預計到2030年將達到28億美元，2025年至2030年期間的複合年成長率為17.53%。

這一市場的成長得益於生技藥品和先進療法需求的不斷成長、監管壓力的不斷加大以及核酸檢測等技術進步。

生產擴張還將包括對微生物污染高度敏感的生技藥品、生物相似藥、細胞療法和疫苗。由於這些產品的複雜性和保存期限短，快速的微生物檢測至關重要。製藥業正在經歷快速成長，尤其是在印度、中國和巴西等新興市場。這些地區對學名藥、生物相似藥、疫苗和生技藥品生產設施的投資正在增加。一些生物製藥製造商將其生產委託給 CMO，後者通常採用先進的快速微生物學檢測技術來滿足不同的客戶需求和監管要求。例如，2024 年 1 月，Rapid Micro Biosystems, Inc. 宣布三星生物製劑公司 (Samsung Biologics) 採用其 Growth Direct 平台來增強其微生物品管流程。此次夥伴關係旨在提高效率、確保資料完整性並在三星製造框架內實現可擴展的品管業務。

此外，嚴格的法規遵循是製藥業採用和發展快速微生物學檢測的關鍵促進因素。世界各地的監管機構都實施嚴格的微生物品管標準，以確保藥品的安全性、有效性和品質。 FDA（美國）、EMA（歐洲）和WHO等機構要求嚴格遵守藥典指南（USP、EP、JP等）進行無菌、微生物限量和微生物附著量測試。此外，PAT 等法律規範鼓勵即時微生物監測，以確保製程控制和合規性。快速微生物檢測方法非常適合整合到連續生產系統中。從而促進市場成長。

醫藥快速微生物檢測市場報告重點

  • 按產品分類，試劑和套件部分在 2024 年佔據最大的市場佔有率。其中很大一部分是由於重複使用試劑和套件對生物製藥進行快速微生物檢測。
  • 根據方法論，基於成長的測試領域在 2024 年佔據了市場主導地位。這些方法因其可靠性和被監管機構接受而被廣泛使用。
  • 根據應用，無菌測試領域在 2024 年佔據市場主導地位。快速微生物檢測可確保注射劑和植入劑等無菌產品不含活微生物。
  • 2024年北美地區佔38.16%的市場佔有率。隨著藥物和疫苗開發時間表的加快，尤其是在 COVID-19 大流行期間，該地區對快速微生物學檢測的需求不斷增加，以快速滿足監管要求和市場需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章。

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章 醫藥快速微生物檢測市場：依產品分類的估計與趨勢分析

  • 產品細分儀表板
  • 全球快速藥物微生物檢測市場產品趨勢分析
  • 2018 年至 2030 年全球醫藥快速微生物檢測市場規模及趨勢分析（依產品分類）
  • 裝置
  • 試劑和套件
  • 配件

第 5 章 醫藥快速微生物檢測市場：依方法的估計與趨勢分析

  • 方法論細分儀表板
  • 全球醫藥快速微生物檢測市場方法變異分析
  • 2018 年至 2030 年全球醫藥快速微生物檢測市場規模及趨勢分析（依方法分類）
  • 基於成長的測試
  • 核酸檢測
  • 基於細胞成分的測試
  • 基於可行性的檢測
  • 其他

第6章：快速藥物微生物學檢測市場：按應用分類的估計和趨勢分析

  • 應用程式細分儀表板
  • 全球醫藥快速微生物檢測市場應用變化分析
  • 2018 年至 2030 年全球醫藥快速微生物檢測市場規模及趨勢分析（依應用）
  • 原料檢測
  • 微生物限量檢測
  • 微生物附著量評估
  • 無菌測試
  • 其他

第7章：快速藥物微生物學檢測市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與企業
  • 2024 年企業市場分析
  • 參與企業概況
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • BD
    • bioMerieux
    • Danaher
    • Sartorius AG
    • Abbott
    • QuidelOrtho Corporation
    • Charles River Laboratories
    • Rapid Micro Biosystems, Inc.
Product Code: GVR-4-68040-506-9

Pharmaceutical Rapid Microbiology Testing Market Growth & Trends:

The global pharmaceutical rapid microbiology testing market size is anticipated to reach USD 2.80 billion by 2030 and grow at a CAGR of 17.53% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth is attributed to factors such as the increasing demand for biologics and advanced therapies, growing regulatory pressure, and technological advancements such as nucleic acid-based testing, and growing public concern about the safety of pharmaceuticals has pushed manufacturers to adopt advanced quality control measures, including rapid microbiology testing

Expanding manufacturing includes biologics, biosimilars, cell therapies, and vaccines, which are highly sensitive to microbial contamination. Due to their complexity and shorter shelf lives, rapid microbiology testing is critical for these products. The pharmaceutical industry is experiencing rapid growth, especially in emerging markets such as India, China, and Brazil. These regions are investing in manufacturing facilities for generics, biosimilars, vaccines, and biologics. Several biopharmaceutical manufacturers outsource production to CMOs, which often employ advanced rapid microbiology testing technologies to meet diverse client needs and regulatory requirements. For instance, in January 2024, Rapid Micro Biosystems, Inc. announced that Samsung Biologics had selected its Growth Direct platform to enhance microbial quality control processes. This partnership aims to improve efficiency, ensure robust data integrity, and allow for scalable quality control operations within Samsung's manufacturing framework.

Moreover, stringent regulatory compliance is a key driver of the adoption and growth of rapid microbiology testing in the pharmaceutical industry. Regulatory agencies worldwide impose rigorous microbial quality control standards to ensure the safety, efficacy, and quality of pharmaceutical products. Agencies such as the FDA (United States), EMA (Europe), and WHO require strict adherence to pharmacopeial guidelines (e.g., USP, EP, JP) for sterility, microbial limits, and bioburden testing. In addition, regulatory frameworks such as PAT encourage real-time microbial monitoring to ensure process control and compliance. Rapid microbiology methods integrate well with continuous manufacturing systems. Hence, driving the market growth.

Pharmaceutical Rapid Microbiology Testing Market Report Highlights:

  • Based on product, reagents and kits segment held the largest market share in 2024. The large share is due to the repetitive usage of reagents and kits for carrying out rapid microbiology tests for biopharmaceuticals.
  • Based on technology, the growth-based testing segment dominated the market in 2024. These methods are widely used due to their reliability and acceptance by regulatory agencies.
  • Based on application, the sterility testing segment dominated the market in 2024. Rapid microbiology testing ensures that sterile products, such as injectables and implantables, are free from viable microorganisms.
  • The North American region dominated the market share of 38.16% in 2024. Accelerated drug and vaccine development timelines, especially during the COVID-19 pandemic, have driven demand for rapid microbiology testing to meet regulatory requirements and market demands faster in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technique
    • 1.2.3. Application
  • 1.3. Information Analysis
  • 1.4. Market Formulation & Data Visualization
  • 1.5. Data Validation & Publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information Or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Rapid Microbiology Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technologies Advancements In Rapid Testing
      • 3.2.1.2. Increasing Focus On Quality Control And Rising Microbiology Testing Needs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Expensive Equipment And Technology Hinder Market Adoption.
      • 3.2.2.2. Complex Regulations Slow Down The Approval And Implementation Process.
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Rapid Microbiology Testing Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Pharmaceutical Rapid Microbiology Testing Market Product Movement Analysis
  • 4.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents & Kits
    • 4.5.1. Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Rapid Microbiology Testing Market: Technique Estimates & Trend Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Global Pharmaceutical Rapid Microbiology Testing Market Technique Movement Analysis
  • 5.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Growth-based Testing
    • 5.4.1. Growth-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Nucleic Acid-based Testing
    • 5.5.1. Nucleic Acid-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cellular Component-based Testing
    • 5.6.1. Cellular Component-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Viability-based Testing
    • 5.7.1. Viability-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Other Techniques
    • 5.8.1. Other Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Rapid Microbiology Testing Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Pharmaceutical Rapid Microbiology Testing Market Application Movement Analysis
  • 6.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Raw Material Testing
    • 6.4.1. Raw Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Microbial Limit Testing
    • 6.5.1. Microbial Limit Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Bioburden Assessment
    • 6.6.1. Bioburden Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Sterility Testing
    • 6.7.1. Stability Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Applications
    • 6.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Rapid Microbiology Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Merck KGaA
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. BD
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. bioMerieux
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Danaher
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Sartorius AG
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. QuidelOrtho Corporation
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Charles River Laboratories
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Rapid Micro Biosystems, Inc.
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global pharmaceutical rapid microbiology testing market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 10 North America pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 13 U.S. pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 16 Canada pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 19 Mexico pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 23 Europe pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 26 UK pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 29 Germany pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 France pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 31 France pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 32 France pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 35 Italy pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 38 Spain pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 40 Denmark pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 41 Denmark pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Sweden pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 43 Sweden pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 44 Sweden pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Norway pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Norway pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 47 Norway pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 54 Japan pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 China pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 56 China pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 57 China pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 India pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 59 India pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 60 India pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Australia pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 65 Thailand pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 66 Thailand pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 67 South Korea pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 68 South Korea pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 69 South Korea pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 73 Latin America pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 76 Brazil pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 79 Argentina pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 86 South Africa pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 92 UAE pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 95 Kuwait pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Pharmaceutical Rapid Microbiology Testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Pharmaceutical rapid microbiology testing market driver analysis
  • Fig. 12 Pharmaceutical rapid microbiology testing market restraint analysis
  • Fig. 13 Pharmaceutical rapid microbiology testing market: Porter's analysis
  • Fig. 14 Pharmaceutical rapid microbiology testing market: PESTEL analysis
  • Fig. 15 Pharmaceutical rapid microbiology testing market: Product outlook and key takeaways
  • Fig. 16 Pharmaceutical rapid microbiology testing market: Product market share analysis, 2024 - 2030
  • Fig. 17 Global pharmaceutical rapid microbiology testing market for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global pharmaceutical rapid microbiology testing market for reagents & kits, 2018 - 2030 (USD Million)
  • Fig. 19 Global pharmaceutical rapid microbiology testing market for accessories, 2018 - 2030 (USD Million)
  • Fig. 20 Pharmaceutical rapid microbiology testing market: Technique outlook and key takeaways
  • Fig. 21 Pharmaceutical rapid microbiology testing market: Technique market share analysis, 2024 - 2030
  • Fig. 22 Global pharmaceutical rapid microbiology testing market for growth-based testing analysis, 2018 - 2030 (USD Million)
  • Fig. 23 Global pharmaceutical rapid microbiology testing market for nucleic acid-based testing, 2018 - 2030 (USD Million)
  • Fig. 24 Global pharmaceutical rapid microbiology testing market for cellular component-based testing, 2018 - 2030 (USD Million)
  • Fig. 25 Global pharmaceutical rapid microbiology testing market for viability-based testing, 2018 - 2030 (USD Million)
  • Fig. 26 Global pharmaceutical rapid microbiology testing market for other techniques, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical rapid microbiology testing market: Application outlook and key takeaways
  • Fig. 28 Pharmaceutical rapid microbiology testing market: Application market share analysis, 2024 - 2030
  • Fig. 29 Global pharmaceutical rapid microbiology testing market for raw material testing, 2018 - 2030 (USD Million)
  • Fig. 30 Global pharmaceutical rapid microbiology testing market for microbial limit testing, 2018 - 2030 (USD Million)
  • Fig. 31 Global pharmaceutical rapid microbiology testing market for bioburden assessment, 2018 - 2030 (USD Million)
  • Fig. 32 Global pharmaceutical rapid microbiology testing market for sterility testing, 2018 - 2030 (USD Million)
  • Fig. 33 Global pharmaceutical rapid microbiology testing market for other applications, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Europe pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 UK pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Germany pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 France pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Italy pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Spain pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Norway pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Asia-Pacific pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Japan pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 China pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 India pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Australia pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 MEA pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 UAE pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key company categorization
  • Fig. 64 Company market positioning
  • Fig. 65 Market participant categorization
  • Fig. 66 Strategy framework